SCDM Releases Best Practices for Automated Data Cleaning
Milwaukee,WI
The Society for Clinical Data Management recently published Edit Check Design Principles, a collection of best practices for the creation of edit checks-a key tool for efficiency and data quality.
The chapter is a new addition to SCDM’s Good Clinical Data Management Practices(GCDMP), an award-winning resource for clinical data managers and others involved in medical device, biotechnology, and pharmaceutical trials.
According to SCDM, edit checks are a crucial component of achieving error-free data.
“Trustworthy data are necessary for successful analysis and assessment in clinical research,” said Charlene Dark, CCDM, GCDMP Taskforce leader. “By publishing a set of best practices pertaining to edit check design, SCDM provides a foundation from which Clinical Data Management professionals can create comprehensive data cleaning to meet the highest level of data integrity.”
The new chapter focuses on creating efficient and accurate edit checks, automated review processes used to identify errors in data. It also discusses different types of edit checks and things to consider when working with them.
“The best practices outlined in Edit Check Design Principles are universal and can be applied in any clinical research setting-pharmaceutical, biotech or CRO, U.S.-based or international, paper trials or EDC,” said Melissa Lamb, who serves as a subject matter expert for SCDM’s GCDMP Taskforce. “This chapter is a guide for creating edit checks that result in the common goal of data quality and accuracy.”
The new text is available free to SCDM members, or by purchase to non-members, through the SCDM Web site. A podcast of the chapter is in production and scheduled for release this spring.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
